Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
11/2012
11/22/2012US20120295885 Inhibitors of bruton's tyrosine kinase
11/22/2012US20120295884 Complement pathway modulators and uses thereof
11/22/2012US20120295881 Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
11/22/2012US20120295874 Coferons and methods of making and using them
11/22/2012US20120295856 Fredericamycin derivatives
11/22/2012US20120292609 Compound having triphenylamine structure, and organic electroluminescent device
11/22/2012US20120292606 Aromatic amine derivative, and organic electroluminescent element
11/22/2012CA2836449A1 Kinase inhibitors
11/22/2012CA2835835A1 Pyrrolidinyl urea and pyrrolidinyl thiourea compounds as trka kinase inhibitors
11/22/2012CA2834077A1 Inhibitors of bruton's tyrosine kinase
11/21/2012EP2524916A2 Method for preparing tetrazole methanesulfonic acid salts, and novel compound used in same
11/21/2012EP2524913A1 Nitrogenated heterocyclic ring derivative and organic electroluminescent element comprising same
11/21/2012EP2523949A1 Novel substituted triazole derivatives as gamma secretase modulators
11/21/2012EP2523939A1 Methods for the preparation of indazole-3-carboxyclic acid and n-(s)-1-azabicyclo[2.2.2]oct-3-yl-1h-indazole-3-carboxamide hydrochloride salt
11/21/2012CN102791704A Heterocyclic inhibitors of glutaminyl cyclase (QC, EC 2.3.2.5)
11/21/2012CN102791703A Pyrazines as delta opioid receptor modulators
11/21/2012CN102791697A Amino-pyrimidine compounds as inhibitors of TBKL and/or IKK epsilon
11/21/2012CN102791695A Cyclopentyl- and cycloheptylpyrazoles as FXR modulators
11/21/2012CN102791693A 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors
11/21/2012CN102791687A Novel inhibitors of hepatitis C virus replication
11/21/2012CN102786514A Novel preparation method of eletriptan
11/21/2012CN102786512A N-aryl unsaturated fused ring tertiary amine compound, preparation method thereof and application thereof to tumor resistance
11/21/2012CN102786496A Microwave synthetic method of substituted piperazine compound
11/21/2012CN102786482A Akt蛋白激酶抑制剂 Akt protein kinase inhibitor
11/21/2012CN102786476A Novel compounds as opioid receptor modulators
11/21/2012CN101903342B Substituted N-phenyl-pyrrolidinylmethylpyrrolidine amides and therapeutic use thereof as histamine H3 receptor modulators
11/21/2012CN101484444B Novel pyridazine compound and use thereof
11/21/2012CN101484443B Potentiator of radiation therapy
11/21/2012CN101137382B Immunosuppressive agent and anti-tumor agent comprising heterocyclic compound as active ingredient
11/21/2012CN101018783B Quinoxaline inhibitors of the HEDGEHOG signalling pathway
11/20/2012US8314257 Treatment of CRTH2-mediated diseases and conditions
11/20/2012US8314111 Fused bicyclic motor inhibitors
11/20/2012US8314097 Organic compounds
11/20/2012US8314091 N-benzyl,N'-arylcarbonylpiperazine derivatives
11/20/2012US8314089 Substituted pyrazolamides and their use
11/15/2012WO2012154777A1 Hepatitis c virus inhibitors
11/15/2012WO2012154760A1 Fused heterocyclic compounds as sodium channel modulators
11/15/2012WO2012154249A1 Substituted aminobutyric derivatives as neprilysin inhibitors
11/15/2012WO2012153729A1 Heteroaromatic ring derivative
11/15/2012WO2012152915A1 Benzazepine derivatives, pharmaceutical compositions containing them, and their use in therapy
11/15/2012WO2012152763A1 Substituted indazole derivatives active as kinase inhibitors
11/15/2012WO2012151958A1 Low-toxic 3-pyrazole carboxylic acid amides, preparation methods and uses thereof in manufacture of medicines as cb1 receptor inhibitors
11/15/2012WO2012125981A3 Raf kinase inhibitors
11/15/2012WO2012084852A3 Ectoparasiticidal active substance combinations
11/15/2012US20120289710 Intermediates of neutral endopeptidase inhibitors and preparation method thereof
11/15/2012US20120289571 Polymeric conjugates of aromatic amine containing compounds including releasable urea linker
11/15/2012US20120289526 Imidazolidinedione derivatives
11/15/2012US20120289513 (4-tert-butylpiperazin-2-yl)(piperazin-1-yl)methanone-n-carboxamide derivatives
11/15/2012US20120289507 Organic compounds as smo inhibitors
11/15/2012US20120289505 Inhibitors of diacylglycerol acyl transferase
11/15/2012US20120289493 Fused heterocyclic compounds as ion channel modulators
11/15/2012US20120288871 Modified Carbocyanine Dyes and Their Conjugates
11/15/2012US20120287524 Novel Compound, Pigment Dispersion Composition and Photosensitive Resin Composition Including the Same, and Color Filter Using the Same
11/15/2012US20120286257 Quinoxaline Derivative, and Organic Semiconductor Device, Electric Field Light Emitting Device, and Electronic Device Which have the Same
11/15/2012US20120286249 Condensed-cyclic compound, organic light-emitting device comprising the same, and flat panel display apparatus including the device
11/15/2012CA2835688A1 Hepatitis c virus inhibitors
11/15/2012CA2835610A1 Proteostasis regulators
11/15/2012CA2835478A1 Substituted indazole derivatives active as kinase inhibitors
11/15/2012CA2834712A1 Benzazepine derivatives, pharmaceutical compositions containing them, and their use in therapy
11/15/2012CA2834164A1 Fused heterocyclic compounds as sodium channel modulators
11/14/2012EP2521724A2 Agents and methods for treating ischemic and other diseases
11/14/2012EP2521549A1 Therapeutic compounds and related methods of use
11/14/2012CN102781933A Substituted benzoazepines as toll-like receptor modulators
11/14/2012CN102781932A Method for preparing 5-chloro-n-({(5s)-2-oxo-3-[4-(5,6-dihydro-4h-[1,2,4]triazin-1-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophen-2-carboxamide derivative and intermediate used therein
11/14/2012CN102781922A TGR5 agonists
11/14/2012CN102781915A Inhibitors of diacylglycerol acyl transferase
11/14/2012CN102781444A Antitumor agent or postoperative adjuvant chemotherapeutic agent for treatment of hepatocellular carcinoma
11/14/2012CN102775392A N-protection-3, 5-disubstituted indole derivative, its preparation method and application
11/14/2012CN102775391A Method for preparing migraine resistant medicine Almotriptan
11/14/2012CN101891690B Synthesis method of N-substituted-4-amino-quinazoline compound
11/14/2012CN101578273B Hydroxylated and methoxylated cyclopenta [d] pyrimidines as akt protein kinase inhibitors
11/14/2012CN101541747B Biphenyl amide lactam derivatives as inhibitors of 11- beta-hydroxysteroid dehydrogenase 1
11/14/2012CN101475563B 3-amino-4-indole-N-methyl maleimide compound, preparation and use thereof
11/14/2012CN101365679B Methods and compounds for preparing cc-1065 analogs
11/14/2012CN101346371B 4- (3-aminopyrazole) pyrimidine derivatives for use as tyrosine kinase inhibitors in the treatment of cancer
11/14/2012CN101087609B Factor Xa compounds
11/13/2012US8309721 HSP90 inhibitory carbazole derivatives, compositions containing same and use thereof
11/13/2012US8309596 Kallikrein 7 modulators
11/13/2012US8309581 Benzimidazole derivatives
11/13/2012US8309561 Phenylalanine derivatives
11/13/2012US8309550 Kinase inhibitors and their use as pharmaceutical agents
11/13/2012US8309548 Benzene, pyridine, and pyridazine derivatives
11/13/2012US8309543 Compositions useful as inhibitors of voltage-gated sodium channels
11/13/2012US8309126 Dispersible bosentan tablet
11/13/2012CA2454306C Substituted dihydro 3-halo-1h-pyrazole-5-carboxylates their preparation and use
11/08/2012WO2012151138A1 Cyclohexene benzotriazole derivatives
11/08/2012WO2012150826A1 Novel organic electroluminescent compounds and an organic electroluminescent device using the same
11/08/2012WO2012150202A1 Isoindolinone derivatives
11/08/2012WO2012092409A3 Macrocyclic hepatitis c serine protease inhibitors
11/08/2012WO2012083112A3 C- 17 -heteroaryl steroidal compounds as inhibitors of cyp11b, cyp17, and/or cyp21
11/08/2012US20120283441 Method For Producing Pyrimidinylpyrazole Compounds
11/08/2012US20120283440 Crystalline forms of bosentan salts and processes for their preparation
11/08/2012US20120283298 Methods for treating memory impairment
11/08/2012US20120283287 Certain chemical entities, compositions, and methods
11/08/2012US20120283271 Isoindolinone derivatives
11/08/2012US20120283263 Triazine-aryl-bis-indoles and process for preparation thereof
11/08/2012US20120283261 Substituted n-phenylpyrimidin-2-amine analogs as inhibitors of the axl kinase
11/08/2012US20120283260 Bradykinin receptor agonists and uses thereof to treat ocular hypertension and glaucoma
11/08/2012US20120283259 Novel inhibitors
11/08/2012US20120283219 Diaminopteridine derivatives
1 ... 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 ... 626